“a trend toward significance”

FPIA was the most common method of TDM in the African (64.2%) and European regions (42.3%) with a trend toward significance for differences across the regions (p=0.075).

TGF-β showed a trend toward significance ( P = 0.075), while lnc-HNRNPUL2 and SFTPD mRNA were not significant predictors in this analysis (Supplementary Table S7, Supplementary Figure S11).

Other risk factors Our analysis identified postmenopausal status as a potential risk factor for severe CIPN, with a trend toward significance in multivariate analysis (adjusted OR = 1.88, p = 0.075).

There was a correlation between the amount of spontaneous vertical ocular drift in the patients and their corresponding SVV variability in 75° LED roll-tilted position ( p = 0.007, GEE), and a trend toward significance for 75° RED ( p = 0.075, GEE) orientation.

Pairwise comparisons with sequential SIDAK correction indicated significant difference ADHD versus ASD ( p = 0.025), and a trend toward significance between ADHD and TD ( p = 0.075).

Among individuals with T2D, serum 25(OH)D concentrations were marginally associated with IL-6 (R 2 = 0.109, B = 0.076, P = 0.085) in HA with T2D, and there was a trend toward significance with log leptin (R 2 = 0.393, B = − 0.006, P = 0.075) in AA with T2D in regression analysis.

A higher BMI showed a trend toward significance in requiring more ETs ( P = 0.075).

There was no significant relationship between global ICI signal fraction ( T 5,93 = 1.353, p = 0.179 n.s.) or global ICA signal fraction ( T 5,93 = −0.298, p = 0.766 n.s.), but there was a trend toward significance with global ECI signal fraction ( T 5,93 = 1.797, p = 0.0755 n.s.) indicating that AgeAccelGrim may be signaling the presence of extracellular water in the aging brain (Figure 5a ). 3.3.

The difference in frequency of DM among hospitalized and nonhospitalized patients showed a trend toward significance ( p =0.0758).

While statistical significance was not achieved, our results indicate a trend toward significance (p-value = 0.076).

Similarly, triglycerides AUC (0–240) was also lower following HIT than following MCT, with a trend toward significance (24%, P = 0.076).

Verbal agitation has a single explanatory variable with a trend toward significance: maximum HR, β = 0.492, p = .076.

Although not statistically significant, CBT showed a trend toward significance on the persecutory beliefs subscale ( p = 0.076) and total beliefs about voices ( p = 0.056).

Diabetes showed a trend toward significance (OR = 2.11, 95% CI: 0.93–4.85, p = 0.076), while age, hemoglobin, RBC and serum potassium were not significant. 3.4.

A trend toward significance was obtained in main effects for condition and time of ability to concentration ( F (1,15) = 3.64, P = 0.076, η p 2 = 0.20 and F (2.30, 34.46) = 3.04, P = 0.054, η p 2 = 0.17, respectively).

A Welch’s two-sample t test of PC1 scores revealed that AHR activation showed a trend toward significance ( t = 2.68, p = 0.076), whereas no meaningful effects were observed for other pathways: AR (t = 0.48, p = 0.68), ER ( t = − 0.93, p = 0.43), and SP1 ( t = 0.37, p = 0.74) (Supplementary Fig. 4c ).

54.60 ± 8.28), and while this difference did not reach statistical significance, it showed a trend toward significance ( p = 0.076), suggesting a potential group effect.

However, pairwise comparisons revealed a trend toward significance in age at seizure onset, with lower values observed in variant C compared to variant A (median onset: 5 vs. 13 months, p = 0.076).

= 32.00 , p < 0.001), with a trend toward significance at 10 −5 (linear regression model: t = 2.08, d.f . = 32, p = 0.076).

All results remained statistically significant except for PSE’s effect on TUG, which showed a trend toward significance ( p = 0.076) in the ITT analysis (see Supplementary Table S2 and Figures S1 and S2, Supplementary Materials ).

Thrombocytopenia was significantly more prevalent among patients with prolonged hospitalization (p = 0.027), while low serum albumin showed a trend toward significance (p = 0.076).

In addition, the four-way interaction between supplement, physical exercise, BMI, and time for waist circumference showed a trend toward significance ( p = 0.076, ES = 0.036), attributed to the reduction in the trained obese group and the absence of changes in the other groups.

In the multivariate analysis, statistical significance remained for IGF-1 (p = 0.043), while the other hormones showed a trend toward significance but with borderline p-values: PTH (p = 0.076), DHEA-S (p = 0.050), and cortisol (p = 0.062).

Patients who completed treatment with lurasidone had numerically larger decreases in BPRSd scores than the overall LOCF analysis sample; however, there were no significant differences from placebo for either dose group for completers at day 42, perhaps as a result of small sample size. For the PANSS total score (secondary efficacy measure), the LS mean change from baseline to week 6 (LOCF) was significantly greater in the lurasidone 120 mg/day group compared with placebo ( p = 0.009), and a trend toward significance was noted for the lurasidone 40 mg/day group ( p = 0.076) (Table 2 ).

A trend toward significance was present for quadriceps strength (p=0.076; Normal: 93.5±9.1%, 95% CI: 90.8-96.1; Below Normal: 88.4±7.4%, 95% CI: 83.4-93.4) but no group differences were present for hop scores (single: p=0.684; crossover: p=0.630; triple: p=0.724; 6-meter timed: p=0.341), KOS (p=0.119), or GR (p=0.136).